These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 15816541
1. Comparative assessment of the functional p53 status in glioma cells. Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A. Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541 [Abstract] [Full Text] [Related]
2. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Griewe GL, Dean RC, Zhang W, Young D, Sesterhenn IA, Shanmugam N, McLeod DG, Moul JW, Srivastava S. Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467 [Abstract] [Full Text] [Related]
4. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K, Forsyth PA. Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5952-61. PubMed ID: 14676120 [Abstract] [Full Text] [Related]
5. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W. Clin Cancer Res; 1995 Jul 01; 1(7):775-81. PubMed ID: 9816045 [Abstract] [Full Text] [Related]
6. Ethnicity delineates different genetic pathways in malignant glioma. Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M. Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811 [Abstract] [Full Text] [Related]
11. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters. Baumbusch LO, Myhre S, Langerød A, Bergamaschi A, Geisler SB, Lønning PE, Deppert W, Dornreiter I, Børresen-Dale AL. Mol Cancer; 2006 Oct 20; 5():47. PubMed ID: 17054774 [Abstract] [Full Text] [Related]
12. Correlation of p53 immunoreactivity and sequencing in patients with glioma. Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM. Mol Carcinog; 1996 Jan 20; 15(1):1-4. PubMed ID: 8561860 [Abstract] [Full Text] [Related]
13. p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas. Klumb CE, Hassan R, Zalcberg IR, Resende LM, Carriço MK, Maia RC. Pediatr Blood Cancer; 2004 Aug 20; 43(2):115-9. PubMed ID: 15236276 [Abstract] [Full Text] [Related]
14. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. Cancer; 2007 Jun 01; 109(11):2323-33. PubMed ID: 17429838 [Abstract] [Full Text] [Related]
18. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry. von Eckardstein K, Gries H, Bolik E, Cervós-Navarro J, Tschairkin IN, Patt S. Histol Histopathol; 1997 Jul 01; 12(3):611-6. PubMed ID: 9225141 [Abstract] [Full Text] [Related]
19. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Liu Y, Bodmer WF. Proc Natl Acad Sci U S A; 2006 Jan 24; 103(4):976-81. PubMed ID: 16418264 [Abstract] [Full Text] [Related]